Application note: Tracking the fate and purge of impurities
Posted: 30 June 2020 | ACD/Labs | No comments yet
Track the emergence and fate of impurities throughout drug development, attach all the relevant analytical data, and store searchable knowledge.
ELNs are typically used to record route scouting data in process development. Associated analytical information may be accessible as PDF images, however, from the perspective of entity characterization and review, it is not dynamically linked with the individual stage(s) of the process route; is unsearchable, and inaccessible. Read about Luminata software—designed to manage API development data, including impurity tracking to support the development of an optimal impurity control strategy.
Related content from this organisation
- On-demand webinar: How to be a spectral superstar – NMR & MS analysis made easy
- On-demand webinar: Practical considerations for improving high throughput synthesis
- Case study: Takeda streamline analytical handling
- Case study: Better, faster method development at Janssen
- Application note: Tracking the fate and purge of impurities
Related topics
Biopharmaceuticals, Informatics, Lab Automation, Mass Spectrometry, Screening, Spectroscopy
Related organisations
ACD/Labs
